推荐的首剂量是5克时,发现药物耐受性普遍良好,副作用从轻度到中度不等。
At the proposed starting dose of 5 grams, the drug was found to be generally well tolerated with side effects that were mild to moderate.
该药在1999年首次被作为处方药批准使用,而今后需大剂量将该药用于肥胖的药物治疗时仍需持有医师的处方。
The drug, which was originally approved for prescription in 1999, will retain prescription status at higher doses for the medical treatment of obesity.
结论小儿原发性肾病综合征首用常规激素诱导治疗8周,不缓解者可考虑用大剂量地塞米松冲击治疗。
Conclusion Children's primary nephrotic syndrome should be treated for 8 weeks by routine hormone induction therapy, if no remission, impulsion therapy could be used.
应用推荐